文献速递甲状腺疾病

45岁以下I期乳头状甲状腺癌患者的动态风险分层

Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger Than 45 Years of Age.
PubMed 文献 · Thyroid · 2017-10-17

本历史队列研究纳入598例45岁以下I期经典型乳头状甲状腺癌患者,评估动态风险分层与结构性复发的关联及非极佳应答的危险因素。中位随访123个月,不同应答组的结构性复发率差异显著(p < 0.001),广泛性甲状腺外侵犯和结外侵犯是非极佳应答的独立危险因素(p < 0.05)。作者认为动态风险分层可减少不必要的额外治疗。

要点

  • 动态风险分层各应答组的结构性复发率分别为极佳应答4.2%、不确定应答17.1%、生化不完全应答44.7%、结构不完全应答82.6%(p < 0.001)。
  • 广泛性甲状腺外侵犯和结外侵犯是与非极佳应答相关的独立危险因素(p < 0.05)。
  • 作者认为动态风险分层可能通过重新分类初始结构性复发风险估计来减少不必要的额外治疗。

核心结论

  • 动态风险分层可能通过重新分类初始结构性复发风险估计来减少不必要的额外治疗。
  • 将与非极佳应答相关的危险因素应用于初始治疗评估,可能成为45岁以下I期经典型乳头状甲状腺癌患者结构性复发风险更实用且可行的替代指标。

研究设计与样本

  • 历史队列研究,纳入598例45岁以下I期经典型乳头状甲状腺癌患者,均接受全甲状腺切除术后放射性碘残余消融(n = 440)、全甲状腺切除术后未行放射性碘残余消融(n = 23)或仅甲状腺叶切除(n = 135)。

主要发现

  • 中位随访123个月,结构性复发在极佳应答组为4.2%(n = 18/432),不确定应答组为17.1%(18/105),生化不完全应答组为44.7%(17/38),结构不完全应答组为82.6%(19/23),组间比较p < 0.001。
  • 各应答组的无病生存曲线差异显著(p < 0.001)。
  • 广泛性甲状腺外侵犯和结外侵犯是与非极佳应答相关的独立危险因素(p < 0.05)。

关键数值与推荐

  • 结构性复发率:极佳应答4.2%(18/432),不确定应答17.1%(18/105),生化不完全应答44.7%(17/38),结构不完全应答82.6%(19/23)(p < 0.001)。
  • 非极佳应答的独立危险因素:广泛性甲状腺外侵犯和结外侵犯(p < 0.05)。

临床怎么用

  • 作者认为动态风险分层可能通过重新分类初始结构性复发风险估计来减少不必要的额外治疗。
  • 作者认为将与非极佳应答相关的危险因素应用于初始治疗评估,可能成为结构性复发风险更实用且可行的替代指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study validated the dynamic risk stratification (DRS) system with regard to its association with structural recurrence and risk factors associated with non-excellent responses in patients <45 years with stage I classical papillary thyroid cancer (PTC). METHODS: This historical cohort study included 598 patients with stage I classical PTC <45 years of age treated with total thyroidectomy followed by radioactive iodine remnant ablation (n = 440), total thyroidectomy without radioactive iodine remnant ablation (n = 23), and thyroid lobectomy alone (n = 135). RESULTS: The median follow-up period was 123 months. Structural recurrence occurred in 4.2% (n = 18/432) of the patients with an excellent response, 17.1% (18/105) of patients with an indeterminate response, 44.7% (17/38) of patients with a biochemically incomplete response, and 82.6% (19/23) of patients with a structurally incomplete response (p < 0.001) during the follow-up. The disease-free survival curves of each response showed significant differences (p < 0.001). Extensive extrathyroidal extension and extranodal extension were the independent risk factors associated with non-excellent response (p < 0.05). CONCLUSIONS: DRS may reduce unnecessary additional treatments by reclassifying initial risk estimates of structural recurrence. Furthermore, applying the risk factors associated with non-excellent response to initial therapy may be a more useful and viable surrogate of the risk for structural recurrence in stage I PTC patients <45 years of age.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Sung TY, Cho JW, Lee YM, et al. Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger Than 45 Years of Age. Thyroid. 2017. PMID: 28847226. doi:10.1089/thy.2017.0199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。